Clin2
NCT06677242Possibly a fitNot yet recruiting

Tracking outcomes for early uterine cancer

Serous Endometrial Intraepithalial CarcinomaSEIC

Part of Cancer, Women’s health & pregnancy clinical trials.

This study follows patients who have been diagnosed with serous endometrial intraepithelial carcinoma (SEIC), a very early form of uterine cancer that has not spread. The goal is to learn more about the condition and how it is managed, which may help improve future care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have been diagnosed with serous endometrial intraepithelial carcinoma (SEIC), a very early form of uterine cancer that has not spread.
  • You are a woman aged 18 or older.
  • You can read and write in Dutch or English.
  • You have not been diagnosed with or treated for another type of cancer in the past two years.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06354738Recruiting
Endometrial cancer study with genetic and surgical insights

This study looks at combining genetic testing with surgical exams to better understand endometrial cancer. It may help doctors see which treatments could work best for you.

Leuven
NCT05051722Recruiting
Test DNA blood and tissue markers to detect gynecologic cancers

This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.

Phoenix, Arizona
NCT07339384Not yet recruiting
Signatera blood test for early-stage endometrial cancer

This study looks at whether a blood test called Signatera can help find small amounts of cancer DNA after surgery for early-stage endometrial cancer. The goal is to see if this test can help guide treatment decisions and improve outcomes.

Birmingham, Alabama
NCT07062016Recruiting
Studying high-risk endometrial cancer with blood and tissue tests

This trial studies tumor DNA in blood and tissue from people with aggressive endometrial cancer to better understand the disease. You donate samples during surgery and follow-up visits.

Rochester, Minnesota
NCT07821879Recruiting
Early ovarian cancer detection via cervical smear testing

This study looks at whether a standard cervical smear test can help find ovarian cancer earlier. The test searches for genetic changes linked to high-grade serous ovarian cancer in cells collected from the cervix, possibly enabling earlier diagnosis.

Toulouse
NCT07298707Not yet recruiting
Cervical swab test for detecting and monitoring endometrial cancer

This study tests a simple cervical swab (like a Pap smear) to see if it can help find or monitor endometrial cancer or precancerous changes. It aims to find a less invasive way to screen and follow up on this condition.

Hear when a new Serous Endometrial Intraepithalial Carcinoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.